我們已在上線! 進一步了解
AVBP圖示

ArriVent BioPharma

名稱 持股 交易金額 股數
變動
持股
變動
SCM
1
Suvretta Capital Management
New York
US$1.57億 +US$338萬 +114,448 +3%
IAM
2
Infinitum Asset Management
Florida
US$1.54億 +US$854萬 +289,461 +7%
HHLR Advisors
3
HHLR Advisors
Cayman Islands
US$1.36億 – – –
BlackRock
4
BlackRock
New York
US$1.13億 +US$2125萬 +720,095 +28%
OrbiMed
5
OrbiMed
New York
US$1.05億 – – –
Fidelity Investments
6
Fidelity Investments
Massachusetts
US$9654萬 -US$700萬 -237,173 -8%
Octagon Capital Advisors
7
Octagon Capital Advisors
New York
US$6847萬 – – –
Vanguard Capital Management
8
Vanguard Capital Management
Pennsylvania
US$6166萬 +US$726萬 +245,980 +16%
Sofinnova Investments
9
Sofinnova Investments
California
US$5895萬 – – –
State Street
10
State Street
Massachusetts
US$5881萬 +US$802萬 +271,571 +19%
Vivo Capital
11
Vivo Capital
California
US$5844萬 +US$2350萬 +796,181 +90%
Novo Holdings A/S
12
Novo Holdings A/S
Denmark
US$5211萬 -US$1305萬 -442,142 -23%
GCGM
13
General Catalyst Group Management
Massachusetts
US$5193萬 – – –
Logos Global Management
14
Logos Global Management
California
US$3474萬 +US$1918萬 +650,000 +186%
Geode Capital Management
15
Geode Capital Management
Massachusetts
US$3380萬 +US$499萬 +168,974 +21%
D.E. Shaw & Co
16
D.E. Shaw & Co
New York
US$3029萬 +US$1485萬 +503,216 +136%
Goldman Sachs
17
Goldman Sachs
New York
US$2966萬 +US$8,736 +296 +0%
HSG Holding
18
HSG Holding
Hong Kong
US$2304萬 – – –
Point72 Asset Management
19
Point72 Asset Management
Connecticut
US$1969萬 -US$535萬 -181,399 -24%
Millennium Management
20
Millennium Management
New York
US$1524萬 +US$37.6萬 +12,741 +3%
UBS Group
21
UBS Group
Switzerland
US$1524萬 -US$141萬 -47,669 -10%
Balyasny Asset Management
22
Balyasny Asset Management
Illinois
US$1374萬 -US$91萬 -30,834 -7%
Ameriprise
23
Ameriprise
Minnesota
US$1326萬 +US$595萬 +201,561 +112%
Vanguard Portfolio Management
24
Vanguard Portfolio Management
Pennsylvania
US$1165萬 +US$240萬 +81,468 +32%
Northern Trust
25
Northern Trust
Illinois
US$1156萬 +US$189萬 +63,941 +24%